Axsome Therapeutics is a biopharmaceutical company dedicated to developing innovative therapies for central nervous system (CNS) conditions that have few treatment options. Our focus on novel mechanisms of action allows us to create products that significantly improve patient outcomes and expand physicians' treatment choices. We are committed to transforming healthcare in the CNS space with our differentiated and impactful therapies.
